Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
4
Number of overlapping holdings
10.8%
% of GDOC's 39 holdings also in MEDX
13.3%
% of MEDX's 30 holdings also in GDOC
Overlap by Weight
Sector Drift (GDOC minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GDOC |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.7% | 17.3% | 9.7% |
|
ABBVIE INC | 6.4% | 9.5% | 6.4% |
|
MERCK & CO. INC. | 4.0% | 3.5% | 3.5% |
|
ALNYLAM PHARMACEUTICALS INC | 1.7% | 4.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
GDOC Overweight Relative to MEDX
|
BOSTON SCIENTIFIC CORP | 8.3% |
|
INTUITIVE SURGICAL INC | 5.8% |
|
ABBOTT LABORATORIES | 5.2% |
|
UNITEDHEALTH GROUP INC | 5.2% |
|
INSULET CORP | 4.4% |
 |
ASTRAZENECA PLC | 4.2% |
|
COOPER COS INC/THE | 3.8% |
 |
NOVO NORDISK A/S-B | 3.8% |
|
BIOMARIN PHARMACEUTICAL INC | 3.3% |
 |
CSL LIMITED | 3.1% |
GDOC Underweight Relative to MEDX
|
ELI LILLY & CO | -7.6% |
 |
NOVARTIS AG-ADR | -6.9% |
|
AMGEN INC | -5.9% |
|
ASTRAZENECA PLC-SPONS ADR | -5.7% |
|
BRISTOL-MYERS SQUIBB CO | -5.6% |
|
JOHNSON & JOHNSON | -5.0% |
 |
ALKERMES PLC | -4.6% |
|
PFIZER INC | -3.9% |
|
ABBVIE INC | -3.2% |
|
ALNYLAM PHARMACEUTICALS INC | -3.0% |